Another non-inhibitory small-molecule chaperone, NCGC758, was reported to enhance GCase activity and reduce the level of GlcCer, ultimately enhancing the clearance of α-synuclein in iPSC-derived dopaminergic neurons of PD and GD patients (Mazzulli et al., 2016). This evidence concerns the gene SNCA and Parkinson disease.